...onsume 37% of ICU resources. With an estimation of 1.35 million MV patients in the EU for an average of 4-5 days, this represents the enormous expenditure of US$3.3 billion (€3.1 billion) annually. Respinor has developed a novel, small and flexible ultrasound sensor (DiaMon) that provides precise, continuous information on diaphragm movement over prolonged periods of time without the need of direc ...